Can Deep Brain Stimulation Unlock Treatment-Resistant Depression?

Researchers explore using 'brain pacemakers' to treat depression that doesn't respond to standard therapies.

Mar. 28, 2026 at 5:35pm

For about 30% of people with depression, standard medications and therapy don't work - a condition known as treatment-resistant depression. Researchers are now investigating Deep Brain Stimulation (DBS) as a potential option, using implanted electrodes to deliver precise electrical pulses and 'unstick' the brain from a chronic depressive state.

Why it matters

DBS has been approved for Parkinson's and other movement disorders, but is still in clinical trials for mental health. If successful, DBS could offer new hope for patients who haven't found relief with other treatments for severe, long-term depression.

The details

Unlike Parkinson's treatment which targets gray matter, depression DBS targets the brain's 'white matter' communication highways. The effects are more gradual, often taking weeks or months. UT Southwestern is a site for the TRANSCEND trial, a gold-standard double-blind study where neither patients nor doctors know who is receiving active stimulation.

  • The TRANSCEND trial at UT Southwestern is currently underway.
  • If the TRANSCEND trial shows clear benefit, the results could support potential FDA approval of DBS for treatment-resistant depression within about 5 years.

The players

UT Southwestern

A leading academic medical center that is conducting its own clinical trial of DBS for depression and is also a site for the national TRANSCEND trial.

Got photos? Submit your photos here. ›

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.